Home/Filings/4/0000950170-25-062897
4//SEC Filing

Audet Juliette Berangere 4

Accession 0000950170-25-062897

CIK 0001936258other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:56 PM ET

Size

5.5 KB

Accession

0000950170-25-062897

Insider Transaction Report

Form 4
Period: 2025-05-01
Transactions
  • Award

    Option (right to buy)

    2025-05-01+30,00030,000 total
    Exercise: $20.03Exp: 2035-05-01Ordinary Shares (30,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the option will vest on May 1, 2026, the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through such date.

Documents

1 file

Issuer

NewAmsterdam Pharma Co N.V.

CIK 0001936258

Entity typeother

Related Parties

1
  • filerCIK 0002000393

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:56 PM ET
Size
5.5 KB